Article
ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor.
eLife - 16 May 2016
Mounir Zineb, Korn Joshua M, Westerling Thomas, Lin Fallon, Kirby Christina A, Schirle Markus, McAllister Gregg, Hoffman Greg, Ramadan Nadire, Hartung Anke, Feng Yan, Kipp David Randal, Quinn Christopher, Fodor Michelle, Baird Jason, Schoumacher Marie, Meyer Ronald, Deeds James, Buchwalter Gilles, Stams Travis, Keen Nicholas, Sellers William R, Brown Myles, Pagliarini Raymond A
Abstract excerpt
The TMPRSS2:ERG gene fusion is common in androgen receptor (AR) positive prostate cancers, yet its function remains poorly understood. From a screen for functionally relevant ERG interactors, we identify the arginine methyltransferase PRMT5. ERG recruits PRMT5 to AR-target genes, where PRMT5 methylates AR on arginine 761. This attenuates AR recruitment and transcription of genes expressed in differentiated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
